Coherus Biosciences | CHRS - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
AbbVie USD 6.57B 2.82B 2026-06
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
Akebia Therapeutics USD 155.55M 7.1M 2026-06
ALKERMES USD 511.53M 159.98M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Amarin USD 143.56M 12.5M 2026-06
Amgen USD 13.99B 1.95B 2026-06
Baxter International USD 2.15B 133M 2026-06
Biogen USD 1.28B 2.1B 2026-06
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Coherus Biosciences USD 82.92M 32.32M 2026-06
Eli Lilly USD 8.95B 3.67B 2026-06
Fujifilm JPY 170.55B 9.68B 2026-03
Gilead Sciences USD 7.63B 64M 2026-03
Ironwood Pharmaceuticals USD 220.47M 5.01M 2026-03
Merck USD 6.85B 1.52B 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
Pacira USD 205.88M 61.57M 2026-06
Perrigo USD 357.2M 174.4M 2026-03
Pfizer USD 976M 727M 2026-06
PTC Therapeutics USD 1.05B 215.9M 2026-06
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
Teva Pharmaceutical Industries USD 3.74B 185M 2026-03
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06
Xencor USD 44.66M 30.49M 2026-06
Zoetis USD 1.48B 465M 2026-06